18 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Assessment and Management ... Initiative (PAMI ... Agent, Initiation Dose ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Assessment and Management ... Initiative (PAMI ... #Management # ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Assessment and Management ... Initiative (PAMI ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Assessment and Management ... Initiative (PAMI ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Assessment and Management ... Initiative (PAMI ... Nerve #Blocks #Medications ... #Doses #Dosing ... #Table #PAMI
Pharmacologic Treatment of Hyperthyroidism

#Hyperthyroidism #Treatment #Management #Pharmacology #Medications #Comparison #Table #Endocrinology #AAFP #Propylthiouracil #Methimazole
Hyperthyroidism #Treatment #Management ... #Pharmacology #Medications ... #Comparison #Table ... #Endocrinology
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Catecholamine Vasopressor ... Effect Sites and Indications ... #Pathophys #Management ... Catecholamine #Comparison ... #Table #Epi #Norepi
Stress Dose Steroids - Indications and Dosing

SUPPRESSED HPA AXIS:
 prednisone >20mg/day x 3 weeks or more
Stress Dose Steroids ... - Indications and ... StressDose #Steroids #Indications ... #Dosing #Endocrinology ... #Diagnosis #Management
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Assessment and Management ... Initiative (PAMI ... and Nebulized Medications ... #Doses #Dosing ... #Table #PAMI
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #diabetes #medications ... #table #comparison ... #management #endocrinology